TY  - JOUR
T1  - Evaluation of <I>Syzygium jambolanum</I> Methanolic Leaf Extract for Insulin-Like Properties
AU - , S.L. Lim AU - , J.W. Chai AU - , U.R. Kuppusamy 
JO  - Research Journal of Biological Sciences
VL  - 3
IS  - 9
SP  - 1109
EP  - 1114
PY  - 2008
DA  - 2001/08/19
SN  - 1815-8846
DO  - rjbsci.2008.1109.1114
UR  - https://makhillpublications.co/view-article.php?doi=rjbsci.2008.1109.1114
KW  - S. jambolanum leaf extract
KW  -lipogenesis
KW  -lipolysis
KW  -glucose uptake
KW  -rat adipocytes
AB  - Traditionally, the fruits and seeds of <I>Syzygium jambolanum</I> (Lam.) DC [Family: Myrtaceae] have been used to treat diabetes mellitus. Insulin is known to inhibit lipolysis induced by epinephrine as well as promote lipogenesis  and  glucose  uptake  adipocytes.  The  present  study  evaluates  the  insulin-like  properties  of <I>S. jambolanum </I>leaf methanolic extract through lipogenic, anti-lipolytic and glucose uptake activities. Methanolic leaf extract of<I> S. jambolanum </I>induced significant lipogenesis in the dose range of 0.1-10 µg mL <SUP>1</SUP> with the highest activity (114%) at 10 µg mL <SUP>1</SUP>. This extract (1 µg mL <SUP>1</SUP> inhibited 29% of epinephrine (1 µM) induced lipolysis and enhanced the inhibitory effect of insulin against epinephrine induced lipolysis. This extract also inhibited (64% inhibition) of isoproterenol (1 µM) ( -adrenergic agonist) induced lipolysis. However, the extract did not enhance the antilipolytic action of propanolol ( -adrenergic antagonist). Thus, it is possible to speculate that the mode of action of this extract may involve competitive binding at  -adrenergic receptor binding sites. <I>S. jambolanum </I>(0.1-10 µg mL <SUP>1</SUP>) exerted a dose-dependant glucose uptake activity and further  enhanced  insulin  mediated  glucose  uptake  in  primary  rat  adipocytes.  These  results confirm that <I>S. jambolanum</I> methanolic leaf extract has insulin-like properties and may be useful as potential therapeutic agent in the management of hyperglycemia.
ER  - 